I hate to be a killjoy, but I believe that at the moment Goat Serum is very easy to discredit if one wishes to do so. So far there is no preclinical or clinical data about the drug, only anecdotal evidence.
But hopefully it will be as effective as the hype around it has made us hope it is, and also available sooner than thought.
Finn, you are technically correct about the science surrounding Goat Serum. But there are few things I find about Goat Serum that I find especially intriguing, and which may give us some reason to hope.
The experiments they were describing where people could see better immediately after injection, are also intruiging.
I think this is what people with MS want- a drug that will actually improve their quality of life. I know the ABCR drugs are often credited with this, but it's mostly through studies that are pretty suspect in my opinion. What I usually hear from people on ABCR drugs is, "I don't know if it's doing anything for me, but I take it because it is supposed to help."
With Goat Serum, it appears that for some people it might be obviously helpful.
So I'm hopeful for those reasons. If the trial of 40 people is a success, they need to follow it up with a long-term large multi-national trial. (Of course if it shows obvious success in 40 people, that means the drug works pretty well).
If it appears safe after this initial trial, I'm hopeful that the various regulatory agencies will be reasonable about this unconventional drug.
Something else to ponder- if it really does work well, but people have difficulty accessing it because of regulatory agencies, we might have a situation where there is a black-market for Goat Serum, much like AZT in the 1980s. I hope we can avoid that.
But I'd pay a lot of money to take 8 or 10 injections and see what it did to me.
But overall Finn is correct in reminding us that this trial- of only 40 people - could indeed fail, and that we need much more evidence.